Cybin (HELP) Capital Expenditures (2020 - 2025)
Cybin (HELP) posted quarterly Capital Expenditures of -$383000.0 for Q4 2025, down 76.58% year-on-year from -$1.6 million in Q4 2024, and up 12.16% on a QoQ basis from -$436000.0 in Q3 2025.
Cybin (HELP) Capital Expenditures (2020 - 2025) Analysis & Trends
Cybin (HELP) has reported Capital Expenditures for 6 consecutive years, with -$383000.0 the latest figure, recorded in Q4 2025.
- Quarterly Capital Expenditures fell 76.58% year-over-year to -$383000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.3 million (down 1446.03% YoY) and the FY2024 annual result came in at $15584.4, changed N/A from the prior year.
- Capital Expenditures advanced to -$383000.0 in Q4 2025 per HELP's latest filing, from -$436000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for HELP reached as high as $382930.4 in Q1 2024 and fell as low as -$436000.0 in Q3 2025.
- A 5-year average of -$81385.0 and a median of -$39862.8 in 2021 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2021 — Capital Expenditures surged 74.72% — and 2022, when it sank 503.42%.
- Year by year, Capital Expenditures stood at -$17453.4 in 2021, then slumped by 476.77% to -$100666.1 in 2022, then decreased by 25.5% to -$126340.1 in 2023, then plunged by 71.68% to -$216902.3 in 2024, then slumped by 76.58% to -$383000.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$383000.0, -$436000.0, and -$231000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -383,000.00 |
| Dec 31, 2025 | -383,000.00 |
| Sep 30, 2025 | -436,000.00 |
| Sep 30, 2025 | -436,000.00 |
| Jun 30, 2025 | -231,000.00 |
| Jun 30, 2025 | -231,000.00 |
| Dec 31, 2024 | -216,902.29 |
| Dec 31, 2024 | -216,902.29 |
| Mar 31, 2024 | 382,930.42 |
| Mar 31, 2024 | 382,930.42 |
| Dec 31, 2023 | -126,340.11 |
| Dec 31, 2023 | -126,340.11 |
| Feb 28, 2023 | 54,433.59 |
| Feb 28, 2023 | 54,433.59 |
| Sep 30, 2022 | -100,666.11 |
| Sep 30, 2022 | -100,666.11 |
| May 31, 2022 | -8,427.14 |
| May 31, 2022 | -8,427.14 |
| Feb 28, 2022 | 80,965.31 |
| Feb 28, 2022 | 80,965.31 |